Digital AI in cancer diagnostics and devices: Where we are, and wher... While it’s only relatively recently that AI became a household term, the technology is already having a major impact on society.
Oncology Single-cell multi-omics and oncological potential Just like people, no two cancer cells are alike.
Cancer Targeting the ecosystem to make cancer extinct The ICR and The Royal Marsden have embarked on an ambitious research collaboration to disrupt the cancer cell ecosystem.
News Novartis snaps up PI3Kα breast cancer drug in $3bn deal Novartis has agreed to buy a PI3Kα-targeting drug for breast cancer from Synnovation, a potential successor to its Piqray brand, for $2bn upfront.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.